STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

PMV Pharmaceuticals Announces Participation at the Bank of America Healthcare Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

PMV Pharmaceuticals (Nasdaq: PMVP) announced that CEO David H. Mack, Ph.D., will present at the Bank of America Healthcare Conference on May 13, 2021, at 12:30 PM ET. The presentation will discuss PMV's pioneering work in precision oncology and its focus on developing small molecule therapies targeting p53 mutants, which are prevalent in about half of all cancers. The company will also engage in one-on-one meetings with investors during the conference. A replay of the presentation will be accessible on PMV's website.

Positive
  • None.
Negative
  • None.

CRANBURY, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President & Chief Executive Officer, will present at the Bank of America Healthcare Conference on Thursday, May 13, 2021. The company will also participate in one-on-one investor meetings at the conference.

Details on the presentation can be found below.

Bank of America Healthcare Conference
Date:Thursday, May 13, 2021
Time:12:30 PM ET
Webcast:http://www.veracast.com/webcasts/bofa/hc2021/idMy79HJ.cfm

A replay of the presentation will be available by visiting the “Events & Presentations” section of the PMV Pharmaceuticals website.

About PMV Pharma

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.  PMV Pharma is headquartered in Cranbury, New Jersey. For more information, please visit www.pmvpharma.com.

Contact

For Investors & Media:

Winston Kung
Chief Financial Officer
investors@pmvpharma.com


FAQ

What is PMV Pharmaceuticals' focus?

PMV Pharmaceuticals focuses on precision oncology, developing therapies targeting p53 mutants.

When is the Bank of America Healthcare Conference presentation?

The presentation is on May 13, 2021, at 12:30 PM ET.

Where can I watch the PMV Pharmaceuticals presentation?

The presentation can be viewed via the webcast link provided in the press release.

Who will present for PMV Pharmaceuticals at the conference?

CEO David H. Mack, Ph.D., will present at the conference.

PMV Pharmaceuticals, Inc

NASDAQ:PMVP

PMVP Rankings

PMVP Latest News

PMVP Stock Data

82.28M
44.08M
2.3%
80.89%
1.64%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PRINCETON